237 related articles for article (PubMed ID: 12438337)
1. EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis.
Collin M; Svensson MD; Sjöholm AG; Jensenius JC; Sjöbring U; Olsén A
Infect Immun; 2002 Dec; 70(12):6646-51. PubMed ID: 12438337
[TBL] [Abstract][Full Text] [Related]
2. EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity.
Allhorn M; Olsén A; Collin M
BMC Microbiol; 2008 Jan; 8():3. PubMed ID: 18182097
[TBL] [Abstract][Full Text] [Related]
3. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins.
Collin M; Olsén A
Infect Immun; 2001 Nov; 69(11):7187-9. PubMed ID: 11598100
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood.
Eriksson A; Norgren M
Infect Immun; 2003 Jan; 71(1):211-7. PubMed ID: 12496168
[TBL] [Abstract][Full Text] [Related]
5. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG.
Collin M; Olsén A
EMBO J; 2001 Jun; 20(12):3046-55. PubMed ID: 11406581
[TBL] [Abstract][Full Text] [Related]
6. IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes.
von Pawel-Rammingen U; Björck L
Curr Opin Microbiol; 2003 Feb; 6(1):50-5. PubMed ID: 12615219
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of Streptococcus pyogenes EndoS, an immunomodulatory endoglycosidase specific for human IgG antibodies.
Trastoy B; Lomino JV; Pierce BG; Carter LG; Günther S; Giddens JP; Snyder GA; Weiss TM; Weng Z; Wang LX; Sundberg EJ
Proc Natl Acad Sci U S A; 2014 May; 111(18):6714-9. PubMed ID: 24753590
[TBL] [Abstract][Full Text] [Related]
8. Study of the IgG endoglycosidase EndoS in group A streptococcal phagocyte resistance and virulence.
Sjögren J; Okumura CY; Collin M; Nizet V; Hollands A
BMC Microbiol; 2011 May; 11():120. PubMed ID: 21619648
[TBL] [Abstract][Full Text] [Related]
9. Fragments of bacterial endoglycosidase s and immunoglobulin g reveal subdomains of each that contribute to deglycosylation.
Dixon EV; Claridge JK; Harvey DJ; Baruah K; Yu X; Vesiljevic S; Mattick S; Pritchard LK; Krishna B; Scanlan CN; Schnell JR; Higgins MK; Zitzmann N; Crispin M
J Biol Chem; 2014 May; 289(20):13876-89. PubMed ID: 24668806
[TBL] [Abstract][Full Text] [Related]
10. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G.
von Pawel-Rammingen U; Johansson BP; Björck L
EMBO J; 2002 Apr; 21(7):1607-15. PubMed ID: 11927545
[TBL] [Abstract][Full Text] [Related]
11. The IgG-specific endoglycosidases EndoS and EndoS2 are distinguished by conformation and antibody recognition.
Sudol ASL; Crispin M; Tews I
J Biol Chem; 2024 May; 300(5):107245. PubMed ID: 38569940
[TBL] [Abstract][Full Text] [Related]
12. Endopeptidase PepO Regulates the SpeB Cysteine Protease and Is Essential for the Virulence of Invasive M1T1 Streptococcus pyogenes.
Brouwer S; Cork AJ; Ong CY; Barnett TC; West NP; McIver KS; Walker MJ
J Bacteriol; 2018 Apr; 200(8):. PubMed ID: 29378883
[No Abstract] [Full Text] [Related]
13. The streptococcal cysteine protease SpeB is not a natural immunoglobulin-cleaving enzyme.
Persson H; Vindebro R; von Pawel-Rammingen U
Infect Immun; 2013 Jun; 81(6):2236-41. PubMed ID: 23569114
[TBL] [Abstract][Full Text] [Related]
14. Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors.
Honda-Ogawa M; Ogawa T; Terao Y; Sumitomo T; Nakata M; Ikebe K; Maeda Y; Kawabata S
J Biol Chem; 2013 May; 288(22):15854-64. PubMed ID: 23589297
[TBL] [Abstract][Full Text] [Related]
15. EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein.
Sjögren J; Struwe WB; Cosgrave EF; Rudd PM; Stervander M; Allhorn M; Hollands A; Nizet V; Collin M
Biochem J; 2013 Oct; 455(1):107-18. PubMed ID: 23865566
[TBL] [Abstract][Full Text] [Related]
16.
Naegeli A; Bratanis E; Karlsson C; Shannon O; Kalluru R; Linder A; Malmström J; Collin M
J Exp Med; 2019 Jul; 216(7):1615-1629. PubMed ID: 31092533
[No Abstract] [Full Text] [Related]
17. The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis.
Allhorn M; Briceño JG; Baudino L; Lood C; Olsson ML; Izui S; Collin M
Blood; 2010 Jun; 115(24):5080-8. PubMed ID: 20357243
[TBL] [Abstract][Full Text] [Related]
18. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.
Huang W; Giddens J; Fan SQ; Toonstra C; Wang LX
J Am Chem Soc; 2012 Jul; 134(29):12308-18. PubMed ID: 22747414
[TBL] [Abstract][Full Text] [Related]
19. Liquid-liquid diffusion crystallization improves the X-ray diffraction of EndoS, an endo-β-N-acetylglucosaminidase from Streptococcus pyogenes with activity on human IgG.
Trastoy B; Lomino JV; Wang LX; Sundberg EJ
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Dec; 69(Pt 12):1405-10. PubMed ID: 24316841
[TBL] [Abstract][Full Text] [Related]
20. The deficient cleavage of M protein-bound IgG by IdeS: insight into the escape of Streptococcus pyogenes from antibody-mediated immunity.
Su YF; Chuang WJ; Wang SM; Chen WY; Chiang-Ni C; Lin YS; Wu JJ; Liu CC
Mol Immunol; 2011 Oct; 49(1-2):134-42. PubMed ID: 21925735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
